True Health Medical Nets HK$384 Million in Hong Kong IPO
MT Newswires Live
Jun 30
Guangdong True Health Medical Technology Development (HKG:2697) raised HK$384 million in net proceeds from its initial public offering in Hong Kong after pricing the shares below the midpoint of the indicative range.
The surgical robot developer issued 3.56 million shares at HK$126.20 each, less than the HK$127.40 midpoint of the HK$119.30 to HK$135.40 price range, according to a Monday bourse filing.
The Hong Kong public offering portion of the deal was 1,790.4 times subscribed, with 356,480 shares allocated, while the international offering was 2.2 times subscribed, with 3.2 million shares allocated.
True Health Medical is set to debut on the Hong Kong bourse today, June 30.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.